(Press-News.org) A team of researchers from Scotland has used a novel 3D printing technique to arrange human embryonic stem cells (hESCs) for the very first time.
It is hoped that this breakthrough, which has been published today, 5 February, in the journal Biofabrication, will allow three-dimensional tissues and structures to be created using hESCs, which could, amongst other things, speed up and improve the process of drug testing.
In the field of biofabrication, great advances have been made in recent years towards fabricating three-dimensional tissues and organs by combining artificial solid structures and cells; however, in the majority of these studies, animal cells have been used to test the different printing methods which are used to produce the structures.
Co-author of the study, Dr Will Wenmiao Shu, from Heriot-Watt University, said: "To the best of our knowledge, this is the first time that hESCs have been printed. The generation of 3D structures from hESCs will allow us to create more accurate human tissue models which are essential for in vitro drug development and toxicity-testing. Since the majority of drug discovery is targeting human disease, it makes sense to use human tissues."
In the longer term, this new method of printing may also pave the way for incorporating hESCs into artificially created organs and tissues ready for transplantation into patients suffering from a variety of diseases.
In the study, the researchers, from Heriot-Watt University in collaboration with Roslin Cellab, a stem cell technology company, used a valve-based printing technique, which was tailored to account for the sensitive and delicate properties of hESCs.
The hESCs were loaded into two separate reservoirs in the printer and were then deposited onto a plate in a pre-programmed, uniformed pattern.
Once the hESCs were printed, a number of tests were performed to discern how effective the method was. For example, the researchers tested to see if the hESCs remained alive after printing and whether they maintained their ability to differentiate into different types of cells. They also examined the concentration, characterisation and distribution of the printed hESCs to assess the accuracy of the valve-based method.
Dr Shu said: "Using this valve-based method, the printed cells are driven by pneumatic pressure and controlled by the opening and closing of a microvalve. The amount of cells dispensed can be precisely controlled by changing the nozzle diameter, the inlet air pressure or the opening time of the valve.
"We found that the valve-based printing is gentle enough to maintain high stem cell viability, accurate enough to produce spheroids of uniform size, and, most importantly, the printed hESCs maintained their pluripotency – the ability to be differentiated into any other cell type."
Roslin Cellab has a track record of applying new technologies to human stem cell systems and will take the lead in developing 3D stem cell printing for commercial uses.
Jason King, business development manager of Roslin Cellab, said: "This world-first printing of human embryonic stem cell cultures is a continuation of our productive partnership with Heriot-Watt. Normally laboratory grown cells grow in 2D but some cell types have been printed in 3D. However, up to now, human stem cell cultures have been too sensitive to manipulate in this way.
"This is a scientific development which we hope and believe will have immensely valuable long-term implications for reliable, animal-free drug-testing and, in the longer term, to provide organs for transplant on demand, without the need for donation and without the problems of immune suppression and potential organ rejection."
hESCs have received much attention in the field of regenerative medicine. They are originally derived from an early stage embryo to create "stem cell lines" which can be grown indefinitely and differentiate into any cell type in the human body.
"In the longer term, we envisage the technology being further developed to create viable 3D organs for medical implantation from a patient's own cells, eliminating the need for organ donation, immune suppression and the problem of transplant rejection," continued Dr Shu.
### From Tuesday 5 February, this paper can be downloaded from http://iopscience.iop.org/1758-5090/5/1/015013.
Notes to Editors
Contact
1. For further information, a full draft of the journal paper or contact with one of the researchers, contact IOP Press Officer, Michael Bishop:Tel: +44 (0) 1179 301032
E-mail: michael.bishop@iop.org
Development of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates
2. The published version of the paper "Development of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates" (Faulkner-Jones et al 2013 Biofabrication 5 015013) will be freely available online from Tuesday 5 February. It will be available at http://iopscience.iop.org/1758-5090/5/1/015013.
Biofabrication
3. A journal focusing on using cells, proteins, biomaterials and/or other bioactive elements as building blocks to fabricate advanced biological models, medical therapeutic products and non-medical biological systems.
IOP Publishing
4. IOP Publishing provides publications through which leading-edge scientific research is distributed worldwide. IOP Publishing is central to the Institute of Physics (IOP), a not-for-profit society. Any financial surplus earned by IOP Publishing goes to support science through the activities of IOP.Beyond our traditional journals programme, we make high-value scientific information easily accessible through an ever-evolving portfolio of community websites, magazines, conference proceedings and a multitude of electronic services. Focused on making the most of new technologies, we're continually improving our electronic interfaces to make it easier for researchers to find exactly what they need, when they need it, in the format that suits them best. Go to http://ioppublishing.org/.
The Institute of Physics
5. The Institute of Physics is a leading scientific society. We are a charitable organisation with a worldwide membership of more than 45,000, working together to advance physics education, research and application. We engage with policymakers and the general public to develop awareness and understanding of the value of physics and, through IOP Publishing, we are world leaders in professional scientific communications. Go to http://www.iop.org
Funding for the research
6. The research was funded from the Scottish University Physics Alliance's INSPIRE project. INSPIRE funds collaborations between industry and academia in the area of physics and life sciences and is made possible by the Scottish Funding Council. Go to http://www.supa.ac.uk/inspire and http://www.sfc.ac.uk/
3D printing breakthrough with human embryonic stem cells
2013-02-05
ELSE PRESS RELEASES FROM THIS DATE:
'Default' options influence patient choices in advance care directives, Penn study shows
2013-02-05
PHILADELPHIA – Advance care directives allow patients to provide instructions about their preferences for the care they would like to receive if they develop an illness or a life-threatening injury and lose the capacity to make decisions for themselves. While many people may assume that patients have strong preferences for the type and aggressiveness of care they wish to receive near life's end, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania suggests that for many patients, preferences for end-of-life care are constructed ...
Experimental therapy crosses blood-brain barrier to treat neurological disease
2013-02-05
CINCINNATI – Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice.
Posted online in PNAS Early Edition on Feb. 4, the study was led by scientists at Cincinnati Children's Hospital Medical Center.
"This study provides a non-invasive procedure that targets the blood-brain barrier and delivers large-molecule therapeutic agents to treat neurological lysosomal storage disorders," said Dao Pan, PhD, principal investigator ...
Body language can predict outcomes for recovering alcoholics
2013-02-05
To predict whether a problem drinker will hit the bottle again, ignore what they say and watch their body language for displays of shame, a University of British Columbia study finds.
The study, which explored drinking and health outcomes in newly sober recovering alcoholics, is the first to show that physical manifestations of shame – from slumped shoulders to narrow chests – can directly predict a relapse in people who struggle with substances.
"Our study finds that how much shame people display can strongly predict not only whether they will go on to relapse, but ...
20 hours of TV a week almost halves sperm count
2013-02-05
Healthy young men who watch TV for more than 20 hours a week have almost half the sperm count of men who watch very little TV, indicates a study published online in the British Journal of Sports Medicine.
Conversely, men who do 15 or more hours of moderate to vigorous exercise every week have sperm counts that are 73% higher than those who exercise little, the findings show.
Semen quality seems to have deteriorated over the past few decades, although it's not clear why, say the authors.
To find out if an increasingly sedentary lifestyle might be a contributory ...
The last Neanderthals of southern Iberia did not coexist with modern humans
2013-02-05
The theory that the last Neanderthals –Homo neanderthalensis– persisted in southern Iberia at the same time that modern humans –Homo sapiens– advanced in the northern part of the peninsula, has been widely accepted by the scientific community during the last twenty years. An international study, in which researchers of the Spanish National Distance Education University (UNED) participate, questions this hypothesis.
"It is improbable that the last Neanderthals of central and southern Iberia would have persisted until such a late date, approximately 30,000 years ago, as ...
Mutations in ASXL3 cause problems similar to Bohring-Opitz syndrome
2013-02-05
Mutations which affect the gene ASXL3 cause a novel syndrome similar to Bohring-Opitz syndrome, finds a study published in BioMed Central's open access journal Genome Medicine. This molecular definition distinguishes these children from those with Bohring-Opitz, and other similar syndromes, and highlights a technique able to help define rare diseases.
When Dr Ropers from the Max-Planck Institute for Molecular Genetics in Berlin found a child with non-specific symptoms, including small size at birth, difficulties with movement and feeding, severe intellectual disability, ...
Researchers pioneer treatment for viral infection common in children
2013-02-05
Researchers at Imperial College London have discovered a new way in which a very common childhood disease could be treated.
In the first year of life, 65 per cent of babies get infected by Respiratory Syncytial Virus (RSV). This causes bronchiolitis, and is thought to kill nearly 200,000 children every year worldwide.
In 1966 and 1967, vaccines were tested for RSV. These had disastrous effects on the immune response, leading to a worsening of the disease and, in many cases, death. Scientists have so far not been able to fully explain this effect, which continues to ...
Could the humble sea urchin hold the key to carbon capture?
2013-02-05
A chance discovery that sea urchins use Nickel ions to harness carbon dioxide from the sea to grow their exoskeleton could be the key to capturing tonnes of CO2 from the atmosphere.
Experts at Newcastle University, UK, have discovered that in the presence of a Nickel catalyst, CO2 can be converted rapidly and cheaply into the harmless, solid mineral, calcium or magnesium carbonate.
This discovery, which is published today in the academic journal Catalysis Science & Technology, has the potential to revolutionise the way we capture and store carbon enabling us to significantly ...
Study examines potential transmission of AD, Parkinson's disease protein in cadaver hGH
2013-02-05
A group of recipients of cadaver-derived human growth hormone (c-hGH) does not appear to be at increased risk for Alzheimer and Parkinson disease despite their likely exposure to neurodegenerative disease (ND)-associated proteins and elevated risk of infectious prion protein-related disease, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
David J. Irwin, M.D., of the University of Pennsylvania Perelman School of Medicine, Philadelphia, and colleagues looked for evidence for human-to-human transmission of Alzheimer disease (AD), ...
Study suggests glucagon-like peptide-1 receptor agonists related to adolescent weight loss
2013-02-05
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
GLP-1 receptor agonist therapy, approved for adults with type 2 diabetes mellitus, reduces body weight by enhancing satiety and suppressing appetite, even in patients without diabetes, according to the study background.
Aaron S. Kelly, Ph.D., of the University ...